ID K2 [Human thyroid carcinoma] AC CVCL_6308 DR BioSample; SAMN03151644 DR cancercelllines; CVCL_6308 DR Cosmic; 928834 DR Cosmic; 1162846 DR Cosmic; 1789443 DR Wikidata; Q54899267 RX PubMed=9054892; RX PubMed=10646882; RX PubMed=18713817; RX PubMed=20143388; RX PubMed=21868764; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a GLAG-66 derivative (PubMed=20143388). CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00219. CC Population: Caucasian; Italian. CC Doubling time: 23 hours (PubMed=9054892). CC Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line). CC Derived from site: Metastatic; Thyroid gland; UBERON=UBERON_0002046. ST Source(s): PubMed=18713817; PubMed=21868764 ST Amelogenin: X,Y ST CSF1PO: 11,12 ST D13S317: 11,14 ST D16S539: 11,12 ST D18S51: 18 ST D21S11: 30,31.2 ST D3S1358: 18 ST D5S818: 10,11 ST D7S820: 11 ST D8S1179: 15 ST FGA: 21,24 ST TH01: 6,9 ST TPOX: 8 ST vWA: 17,18 DI NCIt; C4035; Thyroid gland papillary carcinoma DI ORDO; Orphanet_146; Differentiated thyroid carcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_9918 ! GLAG-66 SX Male AG 58Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 30 // RX PubMed=9054892; DOI=10.1016/S0360-3016(96)00449-X; RA Challeton de Vathaire, Cecile RA Branea, Felicia RA Schlumberger, Martin RA Gaillard, Nadine RA de Vathaire, Florent RA Badie, Christophe RA Antonini, Patrick RA Parmentier, Claude RT "Characterization and radiosensitivity at high or low dose rate of RT four cell lines derived from human thyroid tumors."; RL Int. J. Radiat. Oncol. Biol. Phys. 37:163-169(1997). // RX PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690; PMCID=PMC3229662; RA Zhao, Mei RA Sano, Daisuke RA Pickering, Curtis R. RA Jasser, Samar A. RA Henderson, Ying C. RA Clayman, Gary L. RA Sturgis, Erich M. RA Ow, Thomas J. RA Lotan, Reuben RA Carey, Thomas E. RA Sacks, Peter G. RA Grandis, Jennifer Rubin RA Sidransky, David RA Heldin, Nils-Erik RA Myers, Jeffrey N. RT "Assembly and initial characterization of a panel of 85 genomically RT validated cell lines from diverse head and neck tumor sites."; RL Clin. Cancer Res. 17:7248-7264(2011). // RX PubMed=18713817; DOI=10.1210/jc.2008-1102; PMCID=PMC2582569; RA Schweppe, Rebecca E. RA Klopper, Joshua Paul RA Korch, Christopher T. RA Pugazhenthi, Umarani RA Benezra, Miriam RA Knauf, Jeffrey A. RA Fagin, James Alexander RA Marlow, Laura A. RA Copland, John Alton 3rd RA Smallridge, Robert Christian RA Haugen, Bryan R. RT "Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer RT cell lines reveals cross-contamination resulting in cell line RT redundancy and misidentification."; RL J. Clin. Endocrinol. Metab. 93:4331-4341(2008). // RX PubMed=20143388; DOI=10.1002/ijc.25242; RA Capes-Davis, Amanda RA Theodosopoulos, George RA Atkin, Isobel RA Drexler, Hans Gunther RA Kohara, Arihiro RA MacLeod, Roderick A.F. RA Masters, John R.W. RA Nakamura, Yukio RA Reid, Yvonne A. RA Reddel, Roger Robert RA Freshney, Robert Ian RT "Check your cultures! A list of cross-contaminated or misidentified RT cell lines."; RL Int. J. Cancer 127:1-8(2010). // RX PubMed=10646882; DOI=10.1054/bjoc.1999.0920; PMCID=PMC2363282; RA Bounacer, Ali RA Schlumberger, Martin RA Wicker, Rene RA du Villard, Jean-Antoine RA Caillou, Bernard RA Sarasin, Alain RA Suarez, Horacio Guillermo RT "Search for NTRK1 proto-oncogene rearrangements in human thyroid RT tumours originated after therapeutic radiation."; RL Br. J. Cancer 82:308-314(2000). //